Clinical Trial

Screening Colonoscopy in Breast Cancer Patients

Completed
View on ClinicalTrials.gov →
Summary
Breast cancer survivors may be at increased risk for developing colorectal polyps and colorectal cancer because of shared genetic, hormonal, and lifestyle-related risk factors. However, the prevalence of colorectal neoplasia in women with breast cancer has not been clearly established. This prospective screening study aims to evaluate the prevalence of colorectal polyps, adenomas, and colorectal cancer detected by screening colonoscopy in women who have completed treatment for breast cancer. The study also investigates whether clinical, pathological, and genetic characteristics of breast cancer are associated with the risk of colorectal neoplasia. All eligible participants undergo screening colonoscopy after completion of breast cancer treatment. The findings of this study may help identify breast cancer survivors who could benefit from individualized colorectal cancer screening strategies and contribute to improving long-term cancer survivorship care.
Trial Details
NCT Number NCT07678099
Lead Sponsor Haydarpasa Numune Training and Research Hospital
Conditions Colorectal Cancer, Breast Cancer, Colorectal Adenoma
Enrollment 216 participants
Start Date 2024-11-12
Primary Completion 2025-11-24 (estimated)
Study Completion 2025-11-26 (estimated)
Updated on ClinicalTrials.gov 2026-07-01